Spatial interplay between PIASy and FIP200 in the regulation of signal transduction and transcriptional activity

Molecular and Cellular Biology

Volumn 28, Issue 8, 2008, Pages 2771-2781

  Martin, Nadine ^a   Schwamborn, Klaus ^a,d   Urlaub, Henning ^b   Gan, Boyi ^c   Guan, Jun Lin ^c   Dejean, Anne ^a  

^a INSERM   (France)

^b MAX PLANCK INSTITUTE FOR BIOPHYSICAL CHEMISTRY   (Germany)

^c UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^d Pepscan Systems   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

FOCAL ADHESION KINASE; PROTEIN FIP200; PROTEIN INHIBITOR OF ACTIVATED STAT; PROTEIN P21; S6 KINASE; SUMO PROTEIN; UBIQUITIN PROTEIN LIGASE E3; UNCLASSIFIED DRUG;

ARTICLE; CARBOXY TERMINAL SEQUENCE; CELL FRACTIONATION; CELL NUCLEUS; CHROMATIN IMMUNOPRECIPITATION; CONTROLLED STUDY; CYTOPLASM; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE MICROSCOPY; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN PROTEIN INTERACTION; REGULATORY MECHANISM; RNA INTERFERENCE; SIGNAL TRANSDUCTION; SUMOYLATION; TRANSCRIPTION INITIATION; TRANSCRIPTION REGULATION;

ANIMALS; CALCIUM-BINDING PROTEINS; CELLS, CULTURED; GENE EXPRESSION REGULATION; HUMANS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; MICE; PROMOTER REGIONS (GENETICS); PROTEIN BINDING; PROTEIN INHIBITORS OF ACTIVATED STAT; PROTEIN TRANSPORT; PROTEIN-TYROSINE KINASES; RIBOSOMAL PROTEIN S6 KINASES, 70-KDA; SIGNAL TRANSDUCTION; SMALL UBIQUITIN-RELATED MODIFIER PROTEINS; TRANSCRIPTION, GENETIC;

EID: 42149130922     PISSN: 02707306     EISSN: None     Source Type: Journal    
DOI: 10.1128/MCB.01210-07     Document Type: Article

References (42)

1. Abbi, S., H. Ueda, C. Zheng, L. A. Cooper, J. Zhao, R. Christopher, and J.-L. Guan. 2002. Regulation of focal adhesion kinase by a novel protein inhibitor FIP200. Mol. Biol. Cell 13:3178-3191.
2. Bischof, O., K. Schwamborn, N. Martin, A. Werner, C. Sustmann, R. Grosschedl, and A. Dejean. 2006. The E3 SUMO ligase PIASy is a regulator of cellular senescence and apoptosis. Mol. Cell 22:783-794.
3. Chano, T., S. Ikegawa, K. Kontani, H. Okabe, N. Baldini, and Y. Saeki. 2002. Identification of RB1CC1, a novel human gene that can induce RB1 in various human cells. Oncogene 21:1295-1298.
4. Chano, T., S. Ikegawa, F. Saito-Ohara, J. Inazawa, A. Mabuchi, Y. Saeki, and H. Okabe. 2002. Isolation, characterization and mapping of the mouse and human RB1CC1 genes. Gene 291:29-34.
5. Chano, T., K. Kontani, K. Teramoto, H. Okabe, and S. Ikegawa. 2002. Truncating mutations of RB1CC1 in human breast cancer. Nat. Genet. 31:285-288.
6. Chano, T., M. Saji, H. Inoue, K. Minami, T. Kobayashi, O. Hino, and H. Okabe. 2006. Neuromuscular abundance of RB1CC1 contributes to the non-proliferating enlarged cell phenotypc through both RB1 maintenance and TSC1 degradation. Int. J. Mol. Med. 18:425-432.
7. Chung, C. D., J. Liao, B. Liu, X. Rao, P. Jay, P. Berta, and K. Shuai. 1997. Specific inhibition of Stat3 signal transduction by PIAS3. Science 278:1803-1805.
8. David, G., M. A. Neptune, and R. A. DePinho. 2002. SUMO-1 modification of histone deacetylase 1 (HDAC1) modulates its biological activities. J. Biol. Chem. 277:23658-23663.
9. Gan, B., and J.-L. Guan. 1 November 2007, posting date. FIP200, a key signaling node to coordinately regulate various cellular processes. Cell Signal. doi:10.1016/j.cellsig.2007.10.021.
10. Gan, B., Z. K. Melkoumian, X. Wu, K. L. Guan, and J.-L. Guan. 2005. Identification of FIP200 interaction with the TSC1-TSC2 complex and its role in regulation of cell size control. J. Cell Biol. 170:379-389.
11. Gan, B., X. Peng, T. Nagy, A. Alcaraz, H. Gu, and J.-L. Guan. 2006. Role of FIP200 in cardiac and liver development and its regulation of TNFα and TSC-mTOR signaling pathways. J. Cell Biol. 175:121-133.
12. Gill, G. 2005. Something about SUMO inhibits transcription. Curr. Opin. Genet. Dev. 15:536-541.
13. Gostissa, M., A. Hengstermann, V. Fogal, P. Sandy, S. E. Schwarz, M. Scheffner, and G. Del Sal. 1999. Activation of p53 by conjugation to the ubiquitin-like protein SUMO-1. EMBO J. 18:6462-6471.
14. Hay, N., and N. Sonenberg. 2004. Upstream and downstream of mTOR. Genes Dev. 18:1926-1945.
15. Hay, R. T. 2005. SUMO: a history of modification. Mol. Cell 18:1-12.
16. Ihara, M., H. Yamamoto, and A. Kikuchi. 2005. SUMO-1 modification of PIASy, an E3 ligase, is necessary for PIASy-dependent activation of Tcf-4. Mol. Cell. Biol. 25:3506-3518.
17. Johnson, E. S. 2004. Protein modification by SUMO. Annu. Rev. Biochem. 73:355-382.
18. Johnson, E. S., and A. A. Gupta. 2001. An E3-like factor that promotes SUMO conjugation to the yeast septins. Cell 106:735-744.
19. Kaeser, M. D., and R. D. Iggo. 2002. Chromatin immunoprecipitation analysis fails to support the latency model for regulation of p53 DNA binding activity in vivo. Proc. Natl. Acad. Sci. USA 99:95-100.
20. Kirsh, O., J. S. Seeler, A. Pichler, A. Gast, S. Muller, E. Miska, M. Mathieu, A. Harel-Bellan, T. Kouzarides, F. Melchior, and A. Dejean. 2002. The SUMO E3 ligase RanBP2 promotes modification of the HDAC4 deacetylase. EMBO J. 21:2682-2691.
21. Kwek, S. S., J. Derry, A. L. Tyner, Z. Shen, and A. V. Gudkov. 2001. Functional analysis and intracellular localization of p53 modified by SUMO-1. Oncogene 20:2587-2599.
22. Kwiatkowski, D. J. 2003. Tuberous sclerosis: from tubers to mTOR. Ann. Hum. Genet. 67:87-96.
23. Lee, H., J. C. Quinn, K. V. Prasanth, V. A. Swiss, K. D. Economides, M. M. Camacho, D. L. Spector, and C. Abate-Shen. 2006. PIAS1 confers DNA-binding specificity on the Msx1 homeoprotein. Genes Dev. 20:784-794.
24. Liu, B., M. Gross, J. ten Hoeve, and K. Shuai. 2001. A transcriptional corepressor of Stat1 with an essential LXXLL signature motif. Proc. Natl. Acad. Sci. USA 98:3203-3207.
25. Liu, B., S. Mink, K. A. Wong, N. Stein, C. Getman, P. W. Dempsey, H. Wu, and K. Shuai. 2004. PIAS1 selectively inhibits interferon-inducible genes and is important in innate immunity. Nat. Immunol. 5:891-898.
26. Melkoumian, Z. K., X. Peng, B. Gan, X. Wu, and J.-L. Guan. 2005. Mechanism of cell cycle regulation by FIP200 in human breast cancer cells. Cancer Res. 65:6676-6684.
27. Pfeuffer, T., W. Goebel, J. Laubinger, M. Bachmann, and M. Kuhn. 2000. LaXp180, a mammalian ActA-binding protein, identified with the yeast two-hybrid system, co-localizes with intracellular Listeria monocytogenes. Cell. Microbiol. 2:101-114.
28. Roth, W., C. Sustmann, M. Kieslinger, A. Gilmozzi, D. Irmer, E. Kremmer, C. Turck, and R. Grosschedl. 2004. PIASy-deficient mice display modest defects in IFN and Wnt signaling. J. Immunol. 173:6189-6199.
29. Ruvinsky, I., and O. Meyuhas. 2006. Ribosomal protein S6 phosphorylation: from protein synthesis to cell size. Trends Biochem. Sci. 31:342-348.
30. Sachdev, S., L. Bruhn, H. Sieber, A. Pichler, F. Melchior, and R. Grosschedl. 2001. PIASy, a nuclear matrix-associated SUMO E3 ligase, represses LEF1 activity by sequestration into nuclear bodies. Genes Dev. 15:3088-3103.
31. Santti, H., L. Mikkonen, A. Anand, S. Hirvonen-Santti, J. Toppari, M. Panhuysen, F. Vauti, M. Perera, G. Corte, W. Wurst, O. A. Jänne, and J. J. Palvimo. 2005. Disruption of the murine PIASx gene results in reduced testis weight. J. Mol. Endocrinol. 34:645-654.
32. (waf1/cip1) gene promoter via multiple binding sites for p53 and the vitamin D3 receptor. Nucleic Acids Res. 34:543-554.
33. Schmidt, D., and S. Muller. 2003. PIAS/SUMO: new partners in transcriptional regulation. Cell. Mol. Life Sci. 60:2561-2574.
34. Schumm, K., S. Rocha, J. Caamano, and N. D. Perkins. 2006. Regulation of p53 tumour suppressor target gene expression by the p52 NF-κB subunit. EMBO J. 25:4820-4832.
35. Seeler, J. S., and A. Dejean. 2003. Nuclear and unclear functions of SUMO. Nat. Rev. Mol. Cell Biol. 4:690-699.
36. Sharrocks, A. D. 2006. PIAS proteins and transcriptional regulation - more than just SUMO E3 ligases? Genes Dev. 20:754-758.
37. Shevchenko, A., M. Wilm, O. Vorm, and M. Mann. 1996. Mass spectrometric sequencing of proteins silver-stained Polyacrylamide gels. Anal. Chem. 68:850-858.
38. Shuai, K., and B. Liu. 2005. Regulation of gene-activation pathways by PIAS proteins in the immune system. Nat. Rev. Immunol. 5:593-605.
39. Takahashi, Y., T. Kahyo, E. A. Toh, H. Yasuda, and Y. Kikuchi. 2001. Yeast Ull1/Siz1 is a novel SUMO1/Smt3 ligase for septin components and functions as an adaptor between conjugating enzyme and substrates. J. Biol. Chem. 276:48973-48977.
40. Ueda, H., S. Abbi, C. Zheng, and J.-L. Guan. 2000. Suppression of Pyk2 kinase and cellular activities by FIP200. J. Cell Biol. 149:423-430.
41. Ueda, M., J. Ota, Y. Yamashita, Y. L. Choi, R. Ohki, T. Wada, K. Koinuma, Y. Kano, K. Ozawa, and H. Mano. 2003. DNA microarray analysis of stage progression mechanism in myelodysplasia syndrome. Br. J. Haematol. 123:288-296.
42. Wong, K. A., R. Kim, H. Christofk, J. Gao, G. Lawson, and H. Wu. 2004. Protein inhibitor of activated STAT Y (PIASy) and a splice variant lacking exon 6 enhance sumoylation but are not essential for embryogenesis and adult life. Mol. Cell. Biol. 24:5577-5586.